Introducing the Salixium Rapid Antigen Test, the latest innovation in rapid and accurate COVID-19 testing. This easy-to-use test kit provides results in just 15 minutes, allowing for quick and efficient screening of individuals for the presence of the virus. The Salixium Rapid Antigen Test is designed to identify the presence of specific viral proteins in respiratory samples, making it an effective tool for identifying individuals who may be infected with COVID-19. With its rapid turnaround time, this test is ideal for use in a variety of settings, including healthcare facilities, workplaces, and community testing centers. This test kit is user-friendly and requires no specialized equipment, making it accessible for healthcare professionals and individuals alike. The simplicity of the Salixium Rapid Antigen Test makes it an invaluable tool for widespread testing efforts, helping to identify and isolate individuals who may be carrying the virus. In addition to its speed and accuracy, the Salixium Rapid Antigen Test has undergone rigorous testing to ensure its reliability and effectiveness. Its performance has been validated in clinical studies, demonstrating its high sensitivity and specificity in detecting COVID-19. With the Salixium Rapid Antigen Test, you can trust that you are using a cutting-edge testing solution to help control the spread of COVID-19. Its rapid results and ease of use make it an essential tool for screening and monitoring efforts, providing peace of mind for individuals and communities as we continue to navigate the challenges of the pandemic.

Beijing, China - In a groundbreaking development, researchers at Beijing Beier Bioengineering Co., Ltd. have announced a major breakthrough in the fight against Treponema Pallidum, the bacterium that

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise in China specializing in the development and production of in vitro diagnostic reagents, has recently introduced a new Rtk Antigen Self T